CN107075165A - Many sugarwhips of elasticity and application thereof - Google Patents

Many sugarwhips of elasticity and application thereof Download PDF

Info

Publication number
CN107075165A
CN107075165A CN201580051732.6A CN201580051732A CN107075165A CN 107075165 A CN107075165 A CN 107075165A CN 201580051732 A CN201580051732 A CN 201580051732A CN 107075165 A CN107075165 A CN 107075165A
Authority
CN
China
Prior art keywords
elastic foam
hydrogel
embodiment
described
water
Prior art date
Application number
CN201580051732.6A
Other languages
Chinese (zh)
Inventor
G.T.德利-桑蒂
B.黑拉韦
Original Assignee
亚瑟罗凯尔公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201462028508P priority Critical
Priority to US62/028508 priority
Application filed by 亚瑟罗凯尔公司 filed Critical 亚瑟罗凯尔公司
Priority to PCT/US2015/034902 priority patent/WO2016014158A1/en
Publication of CN107075165A publication Critical patent/CN107075165A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08Cellulose derivatives
    • C08L1/26Cellulose ethers
    • C08L1/28Alkyl ethers
    • C08L1/286Alkyl ethers substituted with acid radicals, e.g. carboxymethyl cellulose [CMC]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28Polysaccharides or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/042Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/146Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/36After-treatment
    • C08J9/40Impregnation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/16Materials with shape-memory or superelastic properties
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J2201/00Foams characterised by the foaming process
    • C08J2201/04Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
    • C08J2201/048Elimination of a frozen liquid phase
    • C08J2201/0484Elimination of a frozen liquid phase the liquid phase being aqueous
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J2205/00Foams characterised by their properties
    • C08J2205/02Foams characterised by their properties the finished foam itself being a gel or a gel being temporarily formed when processing the foamable composition
    • C08J2205/022Hydrogel, i.e. a gel containing an aqueous composition
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J2205/00Foams characterised by their properties
    • C08J2205/06Flexible foams
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J2207/00Foams characterised by their intended use
    • C08J2207/10Medical applications, e.g. biocompatible scaffolds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J2301/00Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/08Cellulose derivatives

Abstract

Disclose a kind of elastic foam and the method for manufacturing the foam.The elastic foam includes derivative polyanionic polysaccharide and with open-celled structure.When elastic foam is contacted with water, the formation of foam thixotroping hydrogel.

Description

Many sugarwhips of elasticity and application thereof

The cross reference of related application

The U.S. Provisional Patent Application No. of entitled " elastic foam and application thereof " for being submitted this application claims on July 24th, 2014 62/028,508 rights and interests.The full content of referenced application is incorporated herein by reference.

Background of invention

A. invention field

The present invention relates generally to elastic foam, and relate more specifically to the elastic foam that is made up of derivative polyanionic polysaccharide. The elastic foam can form thixotroping hydrogel when being contacted with water, blood, wound fluid etc..

B. description of Related Art

Medical material (for example, gel or clamping plate) is intended for various surgical procedures (for example, nose and/or operation on nasal sinus) And/or Wound healing and bone regeneration is to control bleeding, oedema, and prevent the adhesion between adjacent soft tissue structure.In recent years, it is existing big Amount makes great efforts to manufacture the material for minimizing bleeding and oedema, its dissolving, biodegradable or become broken after its function is implemented Piece.The example of some current medical materials be Stammberger Sinu-Foam (ArthroCare, Austin, TX), NasoPore® (Polyganics, The Netherlands), XeroGel® (Cogent Therapeutics, Haywood, CA), SepraGel (Genzyme, Corp., Cambridge, MA), and MeroGel and MeroPack, (Medtronic, Jacksonville, FL).These materials are malleable foams And/or gel, still, they tend to keep its shape or provide enough mechanical forces so that soft tissue (such as nose structure) is solid It is fixed.Some in these materials must be stored under refrigeration and/or be packaged in vacuum packaging, to suppress the foam and/or coagulate The thermal degradation and oxidative degradation of glue.Many foamed materials during use must aquation so that Foam Expansion, still, many materials The size of filling cavity enough can not be expanded into and/or enough mechanical strengths are provided with fixed or support soft tissue.These materials Material and other current materials are made up of the various derivatives of polyurethane and/or the polyanionic polysaccharide of crosslinking.Biological it can inhale again The gel and support of receipts are also described in U.S. Patent number 8,313,762 and U.S. Patent Application Publication No. 2003/0187381.

The problem of related to current material, is numerous.First, the material (such as gel) is used only as barrier or dressing (dressing) and cannot be used for will tissue separate.Second, many materials, which become, to be fragmentated or is retained in cavity or wound, and And must physical removal in agglutination.Such removal can make wound deterioration.3rd, many methods for manufacturing the material are related to Cross-linking process, it can increase some steps for producing the material and/or cost.4th, many materials are necessary irradiated or through entering The processing of one step is to cause the chain scission of cross-linking compounds, to promote the degraded of the material.

Summary of the invention

The solution for the problem of having found related to current material.Especially, the solution is a kind of elastic foam, It is made up of derivative polyanionic polysaccharide and has open-cell foam structure.The discovery provides state-of-the art in the field Present in problem some solutions.First, do not require the crosslinking of polyanionic polysaccharide and itself or other polymer with Form three-dimensional porous foams structure.Second, elastic foam has the ability for absorbing liquid after placement.3rd, elastic foam With strong engineering properties, it allows the elastic foam resilience and to keep tissue to separate in deformation, so as to eliminate for machinery The need for clamping plate.4th, elastic foam is flexible and flexible.Shape needed for being cut into and/or size, and/or bending or The ability of folding allows the elastic foam to insert in small and/or narrow passage.5th, the elastic foam, when with waterborne compositions During (such as blood, wound fluid, biofluid, water) contact, thixotroping hydrogel is formed, it, which can be used as dressing, is used to heal Tissue, while being attributed to its thixotropic nature also maintains its structure.After required time amount, the thixotroping hydrogel can pass through dissolving Removed in water or biofluid.Sum it up, the problem of elastic foam of the present invention is related to current medical equipment Good solution.In the context of the present invention other are the discovery that thixotroping hydrogel.

In one aspect of the invention, elastic foam includes derivative polyanionic polysaccharide and with open-cell foam structure. Any polyanionic polysaccharide for producing polysaccharide esters can be known in the art by being suitable for the polyanionic polysaccharide of the present invention (such as cellulose).The non-limiting examples of polyanionic polysaccharide include starch and cellulose.Derivative polyanionic polysaccharide Non-limiting examples include carboxymethyl cellulose, ethylsulfonic acid cellulose, carboxy methyl amylose, 6- chondroitin sulfates, 4- sulphur Aching and limp ossein, dermatan sulfate, alginates, heparin, heparin sulfate or its any combinations.The elastic foam may include 40 wt.% Or more derivative polyanionic polysaccharide.In some embodiments, the derivative polyanionic polysaccharide is soluble. Some aspects of the present invention, the derivative polyanionic polysaccharide, which has, is less than 0.6,0.2 to 0.55 or 0.3 to 0.45 derivative Substitution value, the non-uniform Distribution of deriveding group or its any combinations of thing per monomeric unit.In some cases, this it is poly- cloudy from Sub- polysaccharide has the molecular weight of constant per unit length polyanionic polysaccharide.Be not wishing to be bound by theory, it is believed that it is poly- cloudy from After the derivatization of sub- polysaccharide, deriveding group is prominent from polyanionic polysaccharide skeleton.There is provided by the deriveding group of the protrusion Steric hindrance inhibits the interaction between residual hydroxyl.Therefore it is believed that as more hydroxyls are derived, this it is derivative it is poly- it is cloudy from Sub- polysaccharide is by than quickly aquation (that is, being moisture absorption) of the derivative polyanionic polysaccharide with compared with low degree of substitution.For example, having The carboxymethyl cellulose of substitution value more than or equal to 0.7 is by than the carboxymethyl cellulose moisture absorption with the substitution value less than 0.7 Property is stronger.(exist see, e.g. HoeflerSodium carboxymethyl cellulose, Hercules Inc., In www.scribd.com).Although it was surprisingly found that the present invention foam have less than 0.6 substitution value, they It is moisture absorption and its elasticity can be retained after the water of vaporous form is absorbed.For example, the gross weight based on dried foam, should Elastic foam can absorb 20 to 60 wt.% vapor, and keeps elasticity.Absorbing the extra liquid form of sufficient amount After water, elastic foam formation thixotroping hydrogel.Because the derivative polyanionic polysaccharide and/or elastic foam are not subjected to also Cross linking conditions, so derivative polyanionic polysaccharide or foam are not crosslinking or the natural crosslinking including minimum or self-crosslinking (for example, two kinds of polyanionic polysaccharide molecules are applying the post-crosslinking of heat).For example, the derivative polyanionic polysaccharide includes 1 Wt.% or the polyanionic polysaccharide of less crosslinking.

It is preferred that polyanionic polysaccharide be carboxymethyl cellulose, its have less than 0.6 substitution value, carboxymethyl it is non-homogeneous Distribution or its any combinations.In terms of some of the present invention, the elastic foam contains 40 wt.% or more carboxymethyl cellulose Element, residue is water.The carboxymethyl cellulose can have 50 to 400 kilodaltons, about 100 to about 350 or 200 to about 400,000 roads The molecular weight that you pause.In the present invention in a certain respect, the carboxymethyl cellulose is derived from cotton or velveteen.In some of the present invention Aspect, the carboxymethyl cellulose, which is derived from, includes the regenerated cellulose of about 200 to about 300 monomeric units.In certain of the present invention A little aspects, the carboxymethyl cellulose is derived from artificial silk, and it is highly preferred that derived from viscose staple fibre.For the present invention's Carboxymethyl cellulose can also be derived from cuprammonium rayon, lyocell (lyocell), saponified rayon and modulus artificial silk.

The elastic foam being made up of derivative polyanionic polysaccharide can be porous, and can containing up to 60 wt.% water, And keep elasticity.In some cases, the elastic foam may include about 0.04 to 0.4, about 0.06 to about 0.3 or about 0.1 to The weight ratio of about 0.2 water and derivative polyanionic polysaccharide.The water that the elastic foam can have 20 to 60 wt.% steeps per elasticity Foam gross weight.Although the elastic foam is hygroscopic, the elastic foam is nondeliquescent.It is not intended to by theory about Beam, it is believed that the open-celled structure of the elastic foam allows the water of vaporous form to fill the vesicle in the open-cell foam structure (pocket), to allow water to be absorbed in the less substituted region of polyanionic polysaccharide structure.Such a absorption process allows The elastic foam is hygroscopic, but retains its elasticity.The elastic foam be also flexible, biodegradable or this two Person.The elastic foam is non-liquid, illiquidity foam.In terms of some of the present invention, the elastic foam is obtained from by derivative The thixotroping hydrogel of polyanionic polysaccharide composition.

In another aspect of this invention, thixotroping hydrogel is described.The thixotroping hydrogel is by derivative polyanionic polysaccharide With water composition.The polyanionic polysaccharide can have less than 0.6,0.2 to 0.55 or 0.30 to 0.45 derivative is per monomeric unit Substitution value, and/or deriveding group non-uniform Distribution.The thixotroping hydrogel is more by 3 to 15 wt.% derivative polyanion Sugar composition, residue is water.The thixotroping hydrogel has bending in the range of 200 Pa or higher or about 200 Pa to about 4000 Pa Take stress.It is not wishing to be bound by theory, it is believed that the three-dimensional structure that the thixotroping hydrogel is made up of polysaccharide molecule, many sugars Son is attracted each other in its less substituted region by weak intermolecular attraction, and the gravitation provides the thixotropy of hydrogel Matter.The less substituted region (hydrophobic region) by hardly having in the less substituted region of polyanionic polysaccharide or Produced without deriveding group.The less substituted region is more difficult to aquation, and therefore it is believed that polyanionic polysaccharide it is less The slow aquation in substituted region allow thixotropic gel through when be slowly dissolved in waterborne compositions.This through when slow mechanism dissolved energy Power allows thixotroping hydrogel to serve as the wet dressing of tissue and be attributed to thixotropic nature and retain its structure.The thixotroping of inventive gel One advantage of property is that they maintain its form or shape and with the concentration reduced or the tendency dripped.

The elastic foam of the present invention can be prepared by following steps:(a) obtain what is be made up of derivative polyanionic polysaccharide Hydrogel;(b) hydrogel is made to be subjected to the condition for being enough to freeze the water cooling being included in the hydrogel;(c) make to come from step (b) Hydrogel be subjected to being enough the drying steps to form open celled foam;The open celled foam from step (c) is contacted with water (d) with Form elastic foam.In terms of some of the present invention, step (b) and (c) can be carried out simultaneously, for example, the hydrogel can be through enduring cold It is dry.It is lyophilized to may include at the three phase point of water or following, or it is dried under 0.10 °C and 4.58 torr.In certain situation In, condition step (b) includes making the min of constant temperature 1 that hydrogel is subjected to 0 °C to -5 °C to 30 min and after through one section Temperature is warmed to room temperature by the time.In the other side of the present invention, the drying steps include making the water in step (b) or step (c) Dehydrating agent (such as 95 to 100 wt.% ethanol) is subjected at a temperature of -5 °C to 25 °C for gel until essentially all of water Absorbed by ethanol.The open celled foam obtained in step (c) can be substantially rigid or stiff.In the step of the present invention (d) in, the open celled foam absorbs enough water to form elastic foam, and thus the elastic foam can be deformed after pressure application And return back to its original-shape after pressure is removed.In step (d), the gross weight based on foam, the foam absorbable 20 To 60 wt. % water.In terms of some of the present invention, the water in step (d) is vapor.The foam can be before step (d) Or it is sterilized after step (d).Step (d) can also be combined with step (c) make it that the drying of the foam is remaining in the foam Water is enough to assign open celled foam and interrupted in advance (before foam is completely dried) with the point of elasticity.

The elastic foam can be made to be contoured for inserting in cavity or the hole of object, and/or to separate the relative of object Tissue surface.The foam forming can be made to control bleeding and prevent the adhesion between tissue.In some respects, the foam forming is made For for inserting nose/sinus cavities, ear chamber, cranial cavity, thoracic cavity, abdominal cavity or pelvic cavity.The elastic foam have enough mechanical elasticities with Separate tissue and keep tissue to separate, or for keeping tissue away from bone.In some cases, the elastic foam is used as bandage And/or make its shaping with to Object delivery medicine.In certain aspects of the invention, the elastic foam of the present invention can be applied to handle Nosebleed, wound or for operation technique.In terms of some of the present invention, the elastic foam and/or thixotropic gel can be applied To the nasal cavity of object, and the foam or thixotroping hydrogel can absorb the enough blood from object to stop nosebleed.Work as place When managing wound, the elastic foam can be applied to wound, the elastic foam absorbs the diffusate from wound.When for the behaviour that performs the operation When making, the elastic foam can be inserted in cavity to separate tissue and keep tissue to separate and/or keep tissue away from bone.With After biofluid (for example, blood, nasal mucus or diffusate) contact, the elastic foam can form thixotroping hydrogel, and it may act as Wet dressing.Through when, such as 2 or 3 to 7 days or longer, the thixotroping hydrogel is dissolved in biofluid and/or provided to affected area In the waterborne compositions in domain, the need for the foam or hydrogel that thus avoid the operation removal present invention.

Embodiment 1 to 112 is also disclosed in the context of the present invention.Embodiment 1 is to include following elastic foam: (a) polyanionic polysaccharide derived from;Open-celled structure, when wherein elastic foam with water contact can form thixotroping hydrogel (b). Embodiment 2 is the elastic foam of embodiment 1, wherein derivative polyanionic polysaccharide, which has, is less than 0.6 derivative per single The substitution value of body unit.Embodiment 3 is any elastic foam in embodiment 1 or 2, wherein derivative polyanion is more Sugar has substitution value of 0.2 to 0.55 derivative per monomeric unit.Embodiment 4 is the elastic foam of embodiment 1, wherein Derivative polyanionic polysaccharide is soluble polysaccharide.Embodiment 5 is any elastic foam in embodiment 1 to 4, its Derived polyanionic polysaccharide is carboxymethyl cellulose, ethylsulfonic acid cellulose, carboxy methyl amylose, 6- chondroitin sulfates Element, chondroitin-4-suleate, dermatan sulfate, alginates, heparin or heparin sulfate or its any combinations.Embodiment 6 is to implement The elastic foam of mode 5, wherein derivative polyanionic polysaccharide is ethylsulfonic acid cellulose.Embodiment 7 is embodiment 5 Elastic foam, wherein derivative polyanionic polysaccharide is carboxymethyl cellulose.Embodiment 8 is the elastic foam of embodiment 7, Wherein carboxymethyl cellulose has the non-uniform Distribution of carboxymethyl.Embodiment 9 is any elasticity in embodiment 7 or 8 Foam, wherein carboxymethyl cellulose have the weight of consistent per unit length polymer.Embodiment 10 be embodiment 7 to Any one of 9 elastic foam, wherein carboxymethyl cellulose compound have the molecular weight of 50 to 400 kilodaltons.Embodiment party Formula 11 is any elastic foam in embodiment 7 to 10, and wherein carboxymethyl cellulose is derived from cotton or velveteen.Embodiment party Formula 12 is any elastic foam in embodiment 7 to 10, and wherein carboxymethyl cellulose, which is derived from, includes about 200 to about 300 The regenerated cellulose of individual monomeric unit.Embodiment 13 is any elastic foam in embodiment 7 to 10, wherein carboxymethyl Cellulose is derived from artificial silk.Embodiment 14 is any elastic foam in embodiment 7 to 10, wherein carboxymethyl cellulose Element is derived from viscose staple fibre.Embodiment 15 is any elastic foam in embodiment 7 to 10, and wherein carboxymethyl is fine Dimension element is derived from least one of following:Cuprammonium rayon, lyocell, saponified rayon and modulus artificial silk.Embodiment 16 be any elastic foam in embodiment 1 to 15, and it further comprises water, its reclaimed water and derivative polyanionic polysaccharide Weight ratio in the range of about 0.04 to about 0.6.Embodiment 17 is any elastic foam in embodiment 1 to 14, its Further comprise water, wherein the gross weight based on elastic foam, the amount of water is in the range of 20 to about 60 wt.%.Embodiment 18 Any elastic foam in embodiment 1 to 17, wherein elastic foam comprising 40 wt.% or more it is derivative it is poly- it is cloudy from Sub- polysaccharide.Embodiment 19 is any elastic foam in embodiment 1 to 18, and wherein elastic foam is by including derivative poly- The hydrogel of anion polysaccharide is obtained, and wherein hydrogel has 200 Pa or higher, or in about 200 Pa to about 4000 Pa scopes Interior yield stress.Embodiment 20 is the elastic foam of embodiment 19, wherein hydrogel include amount for hydrogel about 3 to 15 wt.% derivative polyanionic polysaccharide.Embodiment 21 is any elastic foam in embodiment 1 to 20, wherein Elastic foam is flexible.Embodiment 22 is any elastic foam in embodiment 1 to 21, and wherein elastic foam can Absorb 60 wt.% or less water and keep elasticity.Embodiment 23 is any elastic foam in embodiment 1 to 22, Wherein elastic foam is non-liquid, illiquidity foam.Embodiment 24 is any elasticity bubble in embodiment 1 to 23 Foam, wherein derivative polyanionic polysaccharide is not crosslinking, or the crosslinking comprising minimum.Embodiment 25 is embodiment 1 Any elastic foam into 24, wherein derivative polyanionic polysaccharide and/or elastic foam are not subjected to cross linking conditions.Implement Mode 25 is any elastic foam in embodiment 1 to 25, and wherein elastic foam is biodegradable.Embodiment 27 It is any elastic foam in embodiment 1 to 26, wherein elastic foam is porous.Embodiment 28 is embodiment 1 Any elastic foam into 27, wherein elastic foam are nondeliquescents when exposed to vapor.Embodiment 29 is Any elastic foam in embodiment 1 to 28, wherein elastic foam are sterile.Embodiment 30 be embodiment 1 to Any elastic foam in 29, wherein making elastic foam be contoured for inserting in the cavity of object or hole or to separate pair The relative organization surface of elephant.Embodiment 31 is the elastic foam of embodiment 30, wherein controlling out elastic foam shaping Blood simultaneously prevents from adhering to tissue.Embodiment 31 is any elastic foam in embodiment 1 to 30, wherein making elastic foam It is contoured for insertion nose/sinus cavities, ear chamber, cranial cavity, thoracic cavity, abdominal cavity or pelvic cavity.During embodiment 32 is embodiment 1 to 31 Any elastic foam, wherein make elastic foam be contoured for insertion nose/sinus cavities, ear chamber, cranial cavity, thoracic cavity, abdominal cavity or Pelvic cavity.Embodiment 33 is any elastic foam in embodiment 1 to 32, wherein make elastic foam be configured to be used as it is taut Band.Embodiment 34 is any elastic foam in embodiment 1 to 33, and it further comprises medicine.Embodiment 35 is Any elastic foam in embodiment 1 to 34, wherein thixotroping hydrogel can be dissolved in water.Embodiment 36 is to implement The elastic foam of mode 35, some of thixotroping hydrogels are dissolved in water.Embodiment 37 is appointed in embodiment 35 or 36 A kind of elastic foam, wherein thixotroping hydrogel is substantially dissolved in water.

Embodiment 38 is to include following elastic foam:(a) polyanionic polysaccharide derived from, it, which has, is less than 0.6 Substitution value of the derivative per monomeric unit;Open-celled structure (b).Embodiment 39 is the elastic foam of embodiment 38, wherein Substitution value is in the range of 0.2 to 0.55 derivative is per monomeric unit.Embodiment 40 is the elasticity bubble of embodiment 38 or 39 Foam, wherein derivative polyanionic polysaccharide is that carboxymethyl cellulose, carboxy methyl amylose, 6- chondroitin sulfates, 4- sulfuric acid are soft Ossein, dermatan sulfate, alginates, heparin or heparin sulfate or its any combinations.Embodiment 41 is embodiment 40 Elastic foam, wherein derivative polyanionic polysaccharide is carboxymethyl cellulose.Embodiment 42 is the elasticity bubble of embodiment 41 Foam, wherein carboxymethyl cellulose have the molecular weight of 50 to 400 kilodaltons.Embodiment 43 is appointed in embodiment 41 to 42 A kind of elastic foam, wherein carboxymethyl cellulose have the molecular weight of substantially consistent per unit length.Embodiment 44 It is any elastic foam in embodiment 38 to 43, thixotroping hydrogel can be formed when wherein elastic foam is contacted with water. Embodiment 45 is the elastic foam of embodiment 44, and wherein thixotroping hydrogel can be dissolved in water.Embodiment 46 is real The elastic foam of mode 45 is applied, a portion thixotroping hydrogel is dissolved in water.Embodiment 47 is embodiment 45 to 46 In any elastic foam, wherein thixotroping hydrogel is substantially dissolved in water.

Embodiment 48 is to include following elastic foam:(a) polyanionic polysaccharide derived from, it has deriveding group Non-uniform Distribution;Open-celled structure (b).Embodiment 49 is the elastic foam of embodiment 48, and wherein elastic foam connects with water Thixotroping hydrogel can be formed when tactile.Embodiment 50 is the elastic foam of embodiment 49, and wherein thixotroping hydrogel can be molten In Xie Shui.Embodiment 51 is the elastic foam of embodiment 49, and some of thixotroping hydrogels are dissolved in water.Embodiment party Formula 52 is any elastic foam in embodiment 50 to 51, and wherein thixotroping hydrogel is substantially dissolved in water.Embodiment party Formula 53 is any elastic foam in embodiment 48 to 52, wherein derivative polyanionic polysaccharide has taking less than 0.6 Dai Du.Embodiment 54 is the elastic foam of embodiment 53, and wherein substitution value is in the every monomeric unit of 0.2 to 0.55 derivative In the range of.Embodiment 55 is any elastic foam in embodiment 48 to 54, wherein derivative polyanionic polysaccharide is Carboxymethyl cellulose, carboxy methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin, Or heparin sulfate or its any combinations.Embodiment 56 is the elastic foam of embodiment 55, wherein derivative polyanion is more Sugar is carboxymethyl cellulose.Embodiment 57 is the elastic foam of embodiment 56, and wherein carboxymethyl cellulose has 50 to 400 The molecular weight of kilodalton.Embodiment 58 is any elastic foam in embodiment 56 to 57, wherein carboxymethyl cellulose Element has the molecular weight of substantially consistent per unit length.

Embodiment 59 is to include following thixotroping hydrogel:(a) polyanionic polysaccharide derived from, it, which has, is less than 0.6 Substitution value of the individual carboxymethyl per monomeric unit;Water, wherein hydrogel have thixotropic nature (b).Embodiment 60 is embodiment party The thixotroping hydrogel of formula 59, wherein substitution value are in the range of 0.2 to 0.55 derivative is per monomeric unit.Embodiment 61 is real Thixotroping hydrogel any in mode 59 to 60 is applied, wherein derivative polyanionic polysaccharide is carboxymethyl cellulose, carboxymethyl Amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin or heparin sulfate or its is any Combination.Embodiment 62 is the thixotroping hydrogel of embodiment 61, wherein derivative polyanionic polysaccharide is carboxymethyl cellulose. Embodiment 63 is the thixotroping hydrogel of embodiment 62, and wherein carboxymethyl cellulose has the molecule of 200 to 400 kilodaltons Amount.Embodiment 64 is any thixotroping hydrogel in embodiment 62 to 63, and wherein carboxymethyl cellulose has substantially The molecular weight of consistent per unit length.Embodiment 65 is any thixotroping hydrogel in embodiment 59 to 64, wherein Derivative is distributed in polyanionic polysaccharide in a non-uniform manner.Embodiment 66 is any in embodiment 59 to 65 touches Become hydrogel, wherein thixotroping hydrogel has 200 Pa or higher, or surrender in the range of about 200 Pa to about 4000 Pa should Power.Embodiment 67 is the thixotroping hydrogel of embodiment 66, and wherein thixotroping hydrogel is the 3 to 15 of hydrogel comprising amount Wt.% derivative polyanionic polysaccharide.Embodiment 68 is any thixotroping hydrogel in embodiment 58 to 66, wherein Thixotroping hydrogel has three-dimensional structure, and its reclaimed water is included in three-dimensional structure.

Embodiment 69 is to include following thixotroping hydrogel:(a) polyanionic polysaccharide derived from, it has deriveding group Non-uniform Distribution;Water, wherein hydrogel have thixotropic nature (b).Embodiment 70 is the thixotroping water-setting of embodiment 69 Glue, wherein derivative polyanionic polysaccharide has the substitution value for being less than 0.6 derivative per monomeric unit.Embodiment 71 is real The thixotroping hydrogel of mode 70 is applied, wherein substitution value is in the range of 0.2 to 0.55 derivative is per monomeric unit.Embodiment 72 It is any thixotroping hydrogel in embodiment 69 to 71, wherein derivative polyanionic polysaccharide is carboxymethyl cellulose, carboxylic Methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin or heparin sulfate or its Any combinations.Embodiment 73 is the thixotroping hydrogel of embodiment 69, wherein derivative polyanionic polysaccharide is that carboxymethyl is fine Dimension element.Embodiment 74 is the thixotroping hydrogel of embodiment 72, and wherein carboxymethyl cellulose has 200 to 400 kilodaltons Molecular weight.Embodiment 75 is any thixotroping hydrogel in embodiment 73 to 74, and wherein carboxymethyl cellulose has The molecular weight of substantially consistent per unit length.Embodiment 76 is any thixotroping water-setting in embodiment 69 to 75 Glue, wherein derivative are distributed in polyanionic polysaccharide in a non-uniform manner.Embodiment 77 is appointed in embodiment 69 to 76 A kind of thixotroping hydrogel, wherein thixotroping hydrogel have 200 MPa or higher, or in about 200 MPa to about 4000 Mpa models Enclose interior yield stress.Embodiment 78 is the thixotroping hydrogel of embodiment 77, and wherein thixotroping hydrogel is water-setting comprising amount 3 to 10 wt.% of glue derivative polyanionic polysaccharide.Embodiment 79 is any thixotroping water in embodiment 69 to 78 Gel, wherein thixotroping hydrogel have three-dimensional structure, and its reclaimed water is included in three-dimensional structure.Embodiment 80 is embodiment party Any thixotroping hydrogel, is dissolved in water when wherein thixotroping hydrogel is contacted with water in formula 69 to 79.

Embodiment 81 is the method for preparing any of elastic foam any in embodiment 1 to 58, the party Method, which includes (a), makes hydrogel be subjected to the condition for being enough to freeze the water cooling being included in hydrogel;(b) water from step (b) is made Gel is subjected to being enough the drying steps to form open celled foam;Make open celled foam from step (c) with water contact formed (c) Elastic foam.Embodiment 82 is the method for embodiment 81, wherein derivative polyanionic polysaccharide, which has, is less than 0.6 derivative Substitution value of the thing per monomeric unit.Embodiment 83 is the method for embodiment 82, and wherein substitution value is in 0.2 to 0.55 derivative In the range of the every monomeric unit of thing.Embodiment 84 is any method in embodiment 81 to 82, wherein it is derivative it is poly- it is cloudy from Sub- polysaccharide has the non-uniform Distribution of deriveding group.Embodiment 85 is any method in embodiment 81 to 84, wherein Derivative polyanionic polysaccharide is carboxymethyl cellulose, carboxy methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, sulphur Sour dermatan, alginates, heparin or heparin sulfate or its any combinations.Embodiment 86 is the method for embodiment 85, its Derived polyanionic polysaccharide is carboxymethyl cellulose.Embodiment 87 is the method for embodiment 86, and wherein carboxymethyl is fine Dimension element has the molecular weight of 200 to 400 kilodaltons.Embodiment 88 is any method in embodiment 81 to 82, its Middle carboxymethyl cellulose has the molecular weight of substantially consistent per unit length.During embodiment 89 is embodiment 86 to 87 Any method, makes hydrogel be subjected to 0 °C to -5 ° wherein the condition for being enough to make the water cooling included in hydrogel to freeze is included The C min of temperature 1 to 30 min.Embodiment 90 is any method in embodiment 81 to 89, wherein drying steps (b) Being included with freezing step (c) makes the hydrogel in step (a) be subjected to freezing.Embodiment 91 is the method for embodiment 90, its In freeze and be included at three phase point or following, or be dried under 0.1 °C, 4.58 torr.Embodiment party 92 is embodiment Any method in 81 to 91, wherein being enough to be formed the drying steps of open celled foam comprising making in step (b) and/or (c) 95 to 100 wt.% ethanol are subjected at a temperature of -5 to 25 °C for hydrogel until all water is absorbed by ethanol.Embodiment party Formula 93 is any method in embodiment 76 to 87, wherein the open celled foam obtained in step (c) is substantially rigidity Or it is stiff.Embodiment 94 is any method in embodiment 81 to 93, the wherein open celled foam in step (d) Enough water is absorbed to form elastic foam, and wherein the elastic foam can be deformed and after pressure is removed after pressure application Return back to its original-shape.Embodiment 95 is any method in embodiment 81 to 94, the wherein perforate in step (d) The wt. % of foam absorbing 20 are to 60 wt. % water.Embodiment 96 is any method in embodiment 81 to 95, wherein walking Suddenly the water in (d) is vapor.Embodiment 97 is any method in embodiment 76 to 90, and it further comprises bullet Sex vesicle foam sterilizes.

Embodiment 98 is the method that thixotroping hydrogel is formed by any of embodiment 1 to 58 elastic foam, should Method includes making elastic foam contact with being enough to be formed the waterborne compositions of thixotroping hydrogel.Embodiment 99 is embodiment 98 Method, wherein waterborne compositions are blood.Embodiment 100 is the method for embodiment 99, and wherein waterborne compositions come From the diffusate of wound.

Embodiment 101 is the method for nosebleed in process object, and this method includes the nasal administration embodiment party to object Any of formula 1 to 58 elastic foam, wherein elastic foam handle nosebleed.Embodiment 102 is the side of embodiment 101 Method, wherein elastic foam after the contacting blood of object with changing into thixotroping hydrogel.

Embodiment 103 is the method for wound in process object, and this method includes applying embodiment 1 to the wound of object To 58 any elastic foam, wherein elastic foam processing wound.Embodiment 104 is the method for embodiment 103, wherein Elastic foam changes into thixotroping hydrogel after being contacted with the diffusate from wound.Embodiment 105 is embodiment 104 Method, wherein thixotroping hydrogel is dissolved in the diffusate from wound.

Embodiment 106 is the method for nosebleed in process object, and this method includes the nasal administration embodiment party to object Any thixotroping hydrogel of formula 59 to 80, wherein thixotroping hydrogel handle nosebleed.Embodiment 107 is embodiment 106 Method, wherein blood of the thixotroping absorbed from object.Embodiment 108 is any in embodiment 104 to 107 Method, it further comprises providing enough water to nasal cavity to dissolve thixotroping hydrogel.

Embodiment 109 is the method for wound in process object, and this method, which includes applying to the wound of object, to be implemented Any thixotroping hydrogel of mode 59 to 80, wherein thixotroping hydrogel handle wound.Embodiment 110 is embodiment 109 Method, wherein diffusate of the thixotroping absorbed from wound.

Embodiment 111 is the method for absorbing waterborne compositions, and this method includes making waterborne compositions and embodiment party Any elastic foam of formula 1 to 58 or any thixotroping Hydrogel contact of embodiment 59 to 80, wherein waterborne compositions By elastic foam or thixotroping absorbed.Embodiment 112 is the method for embodiment, wherein waterborne compositions be blood or Diffusate.

The definition of this specification included below middle various terms and phrase used in the whole text.

Term is " biodegradable ", and represent can be by biological action breaks into harmless products.

Term " substitution value " refers to the average of the substituent of every monomeric unit of polysaccharide.For example, with 0.2 substitution value Carboxymethyl cellulose (CMC) represent on average, CMC have every 10 dehydrated glucose units of 2 carboxymethyls.Substitution value can Amount based on polymer weight and substituent is determined with stoichiometric manner.

When referring to polysaccharide and/or polysaccharide esters, term " degree of polymerization " should represent the dehydrated glucose of every polysaccharide polymer chain The average of monomeric unit.

Term " nosebleed " represents to bleed from nose or bleeding (such as nose is bleeding).

Term " elastic " refer to bending, stretching or compression after can rebound or resilience forming shape object.

Term is " lyophilized " to represent freeze-dried.

Term " non-uniform Distribution of derivative " or " uneven distribution of derivative " refer to derivative (substituent) many Concentration class on the skeleton of glycopolymers.

Term " non-crosslinked polysaccharide " represents that polyanionic polysaccharide is not deliberately subjected to that polysaccharide and itself and/or other points will be promoted The condition of sub (for example, hyaluronic acid or derivatives thereof) crosslinking, such as heat condition or electrochemical conditions.Generally, above and below the present invention " non-crosslinked polysaccharide " in text include elastic foam of the invention with 1 wt.% or less crosslinking polyanionic polysaccharide or Hydrogel.

The term " thixotroping " referred in the context of the present invention is that gelatinous mass becomes flowable in pressurization, but is worked as Non-current or fixed form ability is returned back to when static.For example, the thixotroping hydrogel of the present invention can flow under stress, still Its non-flowable gel form is returned back to after release pressure.It is in this non-current or immobilized gel form hair that Fig. 5 and 7, which is provided, The non-limiting examples of bright thixotropic gel --- its shape is maintained until it is through stress or pressure.

Term " object " refers to people or mammal.

Term " about " or " close " are defined as close to it is understood by one of ordinary skill in the art that and unrestricted at one In property embodiment, the term is defined as within 10%, preferably within 5%, more preferably within 1%, and most preferably 0.5% Within.

When in claims or specification together with term "comprising" in use, word " one " (" a " or " an's ") makes With can represent " one " (" one "), but its also with " one or more ", " at least one " and " one or more meanings in one " are consistent.

Word " include (comprising) " (and it is any type of include, for example " include (comprise) " and " include (comprises) "), " have (having) " (and it is any type of have, for example " have (have) " and " have (has) "), " including (including) " (and it is any type of including, for example " including (includes) " and " including ") or " contain (containing) " is (and any type of containing for example " containing (contains) " and " contain (include) (contain) it is ") inclusive or opening, and is not excluded for extra, unreferenced key element or method and step.

The method and catalyst of the present invention can "comprising", " consisting of substantially " or " consisting of ":Specification leads to Specific component, composition, composition disclosed in etc..It is non-limiting at one on transition phrase " substantially by ... constitute " Aspect, the basic and novel characteristic of elastic foam of the invention, thixotroping hydrogel and method is that it effectively facilitates hemostasis, control Nosebleed, and/or the ability that mechanical support is provided.

Other objects, features and advantages of the present invention will become apparent from figure below, detailed description and embodiment.So And, it will be appreciated that although the figure, detailed description and embodiment represent the embodiment of the present invention, it is only through illustration side Formula is provided and is not intended to limit.Additionally, it is contemplated that change and modification within the spirit and scope of the present invention is from present description It will be become apparent for those skilled in the art.In a further aspect, the feature from specific aspect can with from other The combinations of features of aspect.For example, the feature from one side can be with the combinations of features from any other aspect.

Brief description

Fig. 1 is the scanning electron micrograph of the embodiment of elastic foam.

Fig. 2 is the photo of the cross-section parts of the embodiment of elastic foam.

Fig. 3 is the photo of the embodiment with the rigid open celled foam (that is, non-elastic foam) before water process.

Fig. 4 A are the photos for the embodiment for applying stressed elastic foam of the invention.

Fig. 4 B be discharge pressure after Fig. 4 A in elastic foam photo.

Fig. 5 depicts the implementation of the thixotroping hydrogel of the invention by the way that water is formed added to the elastic foam of the present invention The photo of mode.

Fig. 6 A depict the schematic diagram of uneven distribution of the deriveding group in derivative cellulose.

Fig. 6 B depict the schematic diagram of non-uniform Distribution of the deriveding group in cellulose.

Fig. 7 depicts the photo of the thixotropic gel of the invention containing the carboxymethyl cellulose mixed with water.

Fig. 8 depicts the flow chart of the method for the elastic foam of the manufacture present invention.

Detailed description of the invention

Although many kinds in the medical material of known dissolvable and/or bioresorbable, these materials have above The defect of general introduction.For example, current medical material may not be elasticity, keep its shape, and/or enough mechanical force be provided To fix soft tissue without other wrapping.Many current mechanical materials are provided with drying regime and require that material is being used Aquation is carried out before, and still, under hydrated state, the material is hardly provided with or without mechanical strength or elasticity, and/or It is dehydrated during use.For example, many kinds in these materials in insertion nasal cavity after must with sterile saline and/ Or nasal spray keeps moistening.One of mechanical problem is that many kinds in these materials pass through polyanionic polysaccharide the reason for potential Crosslinking with itself and/or other crosslinking agents is made.The degree of cross linking can be difficult to control to, and therefore can be produced with inconsistent physics The cross-linked polymer structures of property.Such inconsistency can produce the material in terms of its engineering properties with change, and this can lead Cause the failure of material or not good performance.

This discovery at present may be used by the elastic foam for providing with open-celled structure and being made up of polyanionic polysaccharide to provide The material and/or the inconsistency and the excellent solution of shortcoming of gel obtained.Thixotroping is formed when elastic foam is contacted with water Hydrogel.Elastic foam resilience in deformation, provides structural intergrity to tissue, absorbs liquid after placement, and/or with Liquid can provide wet dressing to promote hemostasis when contacting.

These and other non-limiting aspect of the present invention is provided in following part.

Elastic foam and thixotroping hydrogel

Fig. 1 is the scanning electron micrograph of the embodiment for the elastic foam being made up of carboxymethyl cellulose.Such as institute in Fig. 1 Show, the elastic foam has three-dimensional structure, it has the opening of the interconnection through carboxymethyl cellulose foaming structure.Cause This, the elastic foam has three-dimensional open pores structure.Fig. 2 is the photo of the section part of the elastic foam.As indicated, in fig. 2, should Foam has spongy architecture.Fig. 3 is the photo of the embodiment with the rigid open celled foam before water process.Such as institute in Fig. 3 Show, do not make the foam deformation to foam applying power (for example, finger is pressed against on foam).Therefore, the open celled foam is rigidity And before with water process hardly have to without elasticity.Fig. 4 A and 4B are rigid foams (for example, the bubble in Fig. 3 Foam) after with water process with produce the present invention elastic foam embodiment photo.As shown in Figure 4 A, to elasticity bubble The surface applying power (for example, being pushed down on the surface with finger) of foam moves up the surface of the foam in the side of the power of application (for example, downwards).When removing power (for example, the lifting finger) applied, the surface of the foam returns back to its substantially original shape State, as shown in Figure 4 B.Therefore, the elastic foam can be pressed and return back to its original or base after release pressure Original shape in sheet.In addition, the elastic foam is flexible and flexible.For example, the both sides of the elastic foam can be toward each other Fold, without fractureing or tearing foam surface.The elastic foam also can be compressed, and/or be cut into required size.Such machine Tool property allows elastic foam to be harmonious by the required profile with body cavity or wound, separates tissue and keeps tissue to separate, separation group Knit and keep tissue, there is provided mechanically and/or chemically stopping blooding, to control nosebleed away from bone, prevent adhesion, make bleeding, swelling and water It is swollen to minimize, or its any combinations.After being contacted with waterborne compositions (for example, water, physiological saline or biofluid), the foam Become thixotroping hydrogel.Fig. 5 depicts the embodiment party of the thixotroping hydrogel of the invention by the way that water to be added to the formation of foam The photo of formula.The thixotroping hydrogel and/or foam are positively retained at original position and continued for some time, for example, 2 days, 3 days, 7 days, 10 days Or more long, or until removed by using aqueous dissolution or be dissolved in biofluid.The thixotroping hydrogel and foam through when It is slowly dissolved in waterborne compositions.The rate of dissolution of thixotroping hydrogel and/or foam in water can be by providing to the bubble The amounts of the waterborne compositions of foam and/or thixotroping hydrogel is controlled.It is not wishing to be bound by theory, it is believed that exposed to excessive water (for example, absorbing water more than 60 wt.%) will cause foam to develop into hydrogel, and diffuse into hydrogel with dampening and enter one Walk out of existing concentration gradient (that is, at polyanionic polysaccharide gel and water termination high water content and oligo-anion polyoses content, its The high polyanionic polysaccharide content and low water content thixotropic gel being then increased within hydrogel agglomerate center).Due to crossing over The presence of water and the osmotic gradient at oligo-anion polysaccharide interface, water will continue to diffuse into hydrogel agglomerate.Work as polyanion Polysaccharide concentration is to of about 3 wt.% (that is, with foam or the more water of gel absorption, the percentage by weight of polysaccharide continues to reduce) When, the hydrogel will lose its thixotropic nature and become the sticky polyanionic polysaccharide aqueous solution.As more water are diffused into Hydrogel agglomerate, the viscous aqueous solution, which will be continued thereafter with, becomes diluter.Which is taken, the thixotroping polyanionic polysaccharide gel group Inwardly dissolve at interface of the block experience between gel lump and water.The rheology of gel lump is by the complete thixotroping at the heart therefrom Non-touch to the agglomerate periphery becomes sticky polyanionic polysaccharide solution change.To be expansion between these extreme cases Thixotroping hydrogel and mobile conversion zone, wherein when polyanionic polysaccharide concentration is 3 wt.% or lower, thixotropy is broken It is bad.

Derivative polyanionic polysaccharide

Derivative polyanionic polysaccharide (for example, ester) can be formed by the reaction of polysaccharide and derivative compound.Derivative compound Example include halogenated acid (haloacid), alkyl halide and alkyl oxide etc..The non-limiting reality of derivative polyanionic polysaccharide Example is carboxymethyl cellulose.In one aspect of the invention, the repeat unit with specified quantitative can be obtained (for example, 200-300 Repeat unit) polyanionic polysaccharide.The polyanionic polysaccharide can have in about 50 to about 400 or about 100 to about 300,000 roads Molecular weight in the range of that.The polysaccharide can be the polymer of the β -1,4- connections with numerous dehydrated glucose monomeric units. Following structure can generally be had by being suitable for the polysaccharide of the present invention:

(I)

Wherein n is the degree of polymerization.

The polysaccharide can have the molecular weight of uniform per unit length polymer.In addition, being suitable for the polysaccharide of the present invention It can be in the form of sheet material or fiber.Preferred in terms of, the polysaccharide is in the form of viscose rayon fibre.

Derivative polyanionic polysaccharide (for example, derivative fibre is plain) can be by using methods known in the art, in acylation Polyanionic polysaccharide is set to contact to prepare with alkali in the presence of agent.(see, e.g. U.S. Patent number 4,410,694).It is poly- cloudy from The non-limiting examples of the General reactions of the derivatization of sub- polysaccharide are as follows:

R-OH + NaOH → R-ONa + H2O (1)

R-ONa + ClCH2COONa → R-O-CH2-COONa + NaCl + H2O (2)

Wherein R is the polyanionic polysaccharide with structure (I).

Contact of the acylating agent (for example, monoxone) with polyanionic polysaccharide under a Contact Temperature and time of contact is enough to carry For the derivative polyanionic polysaccharide (for example, carboxymethyl cellulose) with desired substitution value.The amount of derivatization can be by poly- the moon The knowledge of the mean molecule quantity of nonionic polysaccharide, the knowledge of anionic group number and acylated dosage is determined with stoichiometric manner.With In prepare the present invention elastic foam gained derived from polyanionic polysaccharide have be less than about 0.6,0.2 to 0.55 or 0.3 to 0.45 substitution value.In some embodiments, the derivative polyanionic polysaccharide is soluble polysaccharide, for example, sugar.This Polyanionic polysaccharide derived from kind may be independent of the substitution value dissolved.Prepare the non-limiting examples of derivative fibre element It is included in reaction vessel that continuously the akaline liquid of cycle balance passes through viscose rayon fibre.The uniform akaline liquid Esterifying agent and its salt (for example, monoxone and sodium chloroacetate), uniform alkaline reactant including effective dose are (for example, hydroxide Sodium), alcohol (for example, ethanol) and water.The akaline liquid of cycle balance is fine by viscose rayon at a temperature of such as 60 to 70 °C Rayon fiber is changed into carboxymethyl cellulose fiber by dimension duration sufficient.The carboxymethyl cellulose fiber can it is scrubbed simultaneously Alcohol is removed under partial vacuum to produce substantially pure carboxymethyl cellulose fiber.In one aspect of the invention, the carboxylic first Base cellulose fibre can be through Physical Processing (for example, braiding) with easily operated.Similar process can be carried out to produce with polysaccharide derivative Raw carboxy methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin or sulfuric acid liver Element or its any combinations.

The derivatization of polyanionic polysaccharide can cause the non-uniform Distribution of deriveding group.It is not wishing to be bound by theory, it is believed that When non-homogeneous substituted derivative polyanionic polysaccharide and another fluid are blended, gained fluid will have property heterogeneous, Non newtonian mobility, and/or thixotropic nature.Fig. 6 A and 6B are the signals for the uniform heterogeneous texture for describing carboxymethyl cellulose Figure.In fig. 6, cellulose 600 includes the layer and carboxymethyl 102 of cellulosic molecule 100.As indicated, cellulosic molecule 100 Layer is separated by the carboxymethyl 102 of uneven distribution in cellulose.The uneven distribution of the carboxymethyl allows fluid (for example, water) to exist Flowed between the layer of cellulosic molecule, this makes cellulose aquation.Cellulose aquation is set to reduce the hydrogen bond between cellulose layer, and Cellulose dissolution is promoted to enter fluid.It is stated differently, the carboxymethyl cellulose of the carboxymethyl with uneven distribution will be easily molten In Xie Shui.As depicted in figure 6b, the layer of the cellulosic molecule 100 in part 104 is by 102 points of the carboxymethyl of uneven distribution Open, and the layer of the cellulosic molecule in part 106 is not separated and/or without carboxymethyl.It is not wishing to be bound by theory, it is believed that fine The non-derived part of dimension element is combined together by intermolecular interaction, therefore the cellulose of the part is less susceptible to water Change.Therefore, the carboxymethyl cellulose of the part is insoluble or part is insoluble in water.Because the derivative moiety of cellulose is easier to Aquation, thus the carboxymethyl cellulose of the part can part it is solvable or water-soluble.It is attributed to the non-derived of carboxymethyl cellulose Partial insolubility and the solvable property of the derivative moiety of carboxymethyl cellulose, the carboxymethyl cellulose is with enough fluid (examples Such as, 60 wt.% or more water or biofluid) processing when, formed have heterogeneous, non newtonian mobility and thixotropic nature Gel.

C. the preparation of elastic foam and thixotroping hydrogel

Above the derivative polyanionic polysaccharide (for example, carboxymethyl cellulose fiber) described in the B of part be dissolvable in water in water with It is the solidifying of water to produce the derivative polyanionic polysaccharide with about 3 to 15 wt.%, 4 to 9 wt.% or 5 to 8 wt.%, residue Glue.Any kind of water (for example, deionized water, filter water or drinking water) can mix with the polyanionic polysaccharide.The present invention The non-limiting examples of gel are carboxymethyl cellulose hydrogels.In terms of some of the present invention, the gel of generation is thixotroping water Gel.Fig. 7 depicts the photo of the thixotropic gel by the way that water is formed added to the carboxymethyl cellulose of the present invention.The gel And/or thixotroping hydrogel can be used to sell, sterilize through storing, packing, or it is further processed into the elastic foam of the present invention.

The elastic foam of the present invention can be by foregoing derivative polyanionic polysaccharide gel and/or polyanionic polysaccharide thixotroping water Gel by subjecting them to freeze, dry and hydration process is made., can be by by carboxymethyl cellulose in non-limiting examples The gel constituted with water is placed in the mould (for example, the mould of shape as the profiling of nasal cavity) with chosen shape and size In.The mould can be subjected to the temperature of the solidification point less than water, be, for example, less than 0 °C.Reaching after 0 °C, can further pass through When reduce temperature.For example, temperature is reduced the several years, a period of time is then maintained at a lower temperature, and is then reduced again straight To reach it is minimum needed for temperature, such as 0 °C to -5 °C temperature, wherein by sample keep for a period of time (for example, 1 minute extremely 30 minutes).The gel of freezing can be subjected to drying steps to produce dry rigid foams.The drying rigid foams are by about 90 wt.% Or more derivative polyanionic polysaccharide composition, residue is water.In one aspect of the invention, the gel of freezing is under vacuo With 0 °C at a temperature of be subjected to drying.For example, the gel of freezing can be placed in 0.005 torr to about 0.2 torr vacuum ,- Temperature is warmed to room temperature under 40 °C and through a period of time.In terms of some of the present invention, freezing and drying can be used as a mistake Journey, for example, being carried out as freeze-drying process.It is not wishing to be bound by theory, it is believed that freeze thixotroping hydrogel by the water in hydrogel Ice is changed into, and when being dried at the temperature below decompression and 0 °C, ice distils from gel.The distillation of ice preserve and/ Or open rigid foams structure of the three-dimensional structure as the drying with open-celled structure of gel.In another aspect of this invention, Handle dry and/or freezing solidifying at a temperature of -5 °C to 25 °C or -5 °C to 15 °C with 95 to 100 wt.% ethanol Glue, until essentially all of water is removed all from the freezing and/or dried foam.

The Rigid Porous foam that gained is dried can be by being exposed to water (for example, vapor) extremely by the rigid foams of the drying Lack 30 hours to cause it to be elasticity.Water slow-absorbing is allowed to pass through foam master exposed to vapor the rigid foams of the drying Body, this provides the uniform elasticity through foam.As non-limiting examples, the foam can be exposed to about 40 to 100% or 50 Air under to 80% relative humidity about 30 to 48 hours.Absorbable up to 60 wt.% or 20 to 60 of the elastic foam Wt.%, 25 to 50 wt.% or 30 to 40 wt.% water, residue are derivative polyanionic polysaccharides.For example, the elastic foam can Polyanionic polysaccharide and 25 wt.% derived from derivative polyanionic polysaccharide and 20 wt.% water, 75 wt.% as 80 wt.% Water or 60 wt.% derived from polyanionic polysaccharide and 40 wt.% water composition.The elastic foam can be exposed to foam Sterilized before or after water.For example, making dry rigid foams exposed to vapor before being elasticity, this can be steeped Foam sterilizes under the conditions of ethylene oxide.

The elastic foam can be made to be connect with waterborne compositions (for example, water, blood, physiological saline, nasal mucus and wound fluid) Touch to form thixotroping hydrogel.For example, the elastic foam can be handled through a period of time, for example, 2,3 or 10 days contact water.Do not wish Hope bound by theory, it is believed that water causes foam to lose its rigidity and form thixotroping hydrogel via the plain structure of perforate permeable fiber. For example, the amount by changing the fluid (for example, physiological saline) contacted with elastic foam, can change the speed of thixotroping hydrogel formation Rate.It can apply the thixotroping hydrogel as binder or wet dressing to wound or tissue.

D. the purposes of elastic foam

The elastic foam can be used for operation technique, nosebleed processing, treatment of wounds or its any combinations.Generally, institute is effectively handled The period needed can become according to type of surgery, bleeding, the type of involved tissue, and/or involved damage.The elastic foam can be pressed The required profile with body cavity or wound is harmonious, and provides mechanical/chemical hemostasis, control nosebleed, provide mechanical elasticity, prevent from gluing Echo minimum swelling and oedema.Generally, if the elastic foam be used for separate tissue, the tissue should keep separation continue to It is few 48 hours, and preferably last at least time of 2 to 7 days.When the elastic foam and waterborne compositions are (for example, blood, physiology salt Water, nasal mucus and wound fluid) contact when, it will form thixotroping hydrogel.For example, by changing the stream contacted with elastic foam The amount of body (for example, physiological saline), can change the speed of thixotroping hydrogel formation.The elastic foam composition of the present invention especially may be used For preventing the adhesion between organizing after nose and operation on nasal sinus, and available for treatment nosebleed.The elastic foam group of the present invention Compound can be additionally used in other types of operation or treatment of wounds.The specific operation being used for according to elastic foam composition or wound Processing, may be adapted to optimize any required size and dimension of its purposes to provide the elastic foam composition.

The elastic foam of the present invention can be further used for medicine delivery.For example, containing the poly- the moon of water-soluble or part aqueous The elastic foam composition of nonionic polysaccharide can be used for sustained release drug delivery.Medicine to be delivered is dispersed in said composition, or Can be with elastic foam covalent bonding;And then it can be implanted into the elastic foam at the place for needing to deliver.The one of the present invention A little aspects, can apply the thixotroping hydrogel to nasal cavity to control nosebleed, bleeding, and/or provide wet dressing.

Embodiment

The present invention will be explained in more detail by way of specific embodiment.Following examples are provided to be only used for illustrating Purpose, and be not intended to limit the present invention in any way.Those skilled in the art will readily appreciate that what can be altered or modified Various non-key parameters are to obtain essentially identical result.

Embodiment 1

(preparation of elastic foam and thixotroping hydrogel)

Elastic foam can be prepared as general introduction in flow chart as shown in Figure 8.In step 800, artificial silk is changed into carboxylic first Base cellulose braid.The carboxymethyl cellulose braid is dissolved in water to form the carboxymethyl cellulose with about 7 wt.% Element, residue is the gel (step 802) of water.The gel is injected into the mould with the shape and size as nose stretcher (step It is rapid 804).The mould is set to be subjected to freeze-drying condition (step 806) to form the rigid foams as in Fig. 3 described.Make step 806 In rigid foams vapor is subjected to form the elastic foam (step 808) described in Fig. 4 A and 4B.

Claims (30)

1. elastic foam, it is included:
(a) polyanionic polysaccharide derived from;With
(b) open-celled structure,
Wherein described elastic foam can form thixotroping hydrogel when being contacted with water.
2. the elastic foam described in claim 1, wherein the derivative polyanionic polysaccharide is every with 0.6 derivative is less than The substitution value of monomeric unit.
3. the elastic foam described in claim 1, wherein the derivative polyanionic polysaccharide is soluble.
4. the elastic foam described in claim 1, wherein the derivative polyanionic polysaccharide is carboxymethyl cellulose, ethyl sulphur Acid cellulose, carboxy methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin or sulphur Heparin or its any combinations.
5. the elastic foam described in claim 4, wherein the derivative polyanionic polysaccharide is ethylsulfonic acid cellulose.
6. the elastic foam described in claim 4, wherein the derivative polyanionic polysaccharide is carboxymethyl cellulose.
7. the elastic foam described in claim 6, wherein the carboxymethyl cellulose has the non-uniform Distribution of carboxymethyl.
8. the elastic foam described in claim 6, wherein the carboxymethyl cellulose has consistent per unit length polymer Weight.
9. the elastic foam described in claim 6, wherein the carboxymethyl cellulose compound has 50 to 400 kilodaltons Molecular weight.
10. the elastic foam described in claim 6, wherein the carboxymethyl cellulose is derived from cotton or velveteen.
11. the elastic foam described in claim 1, it further includes water, wherein the water and the derivative polyanion The weight ratio of polysaccharide is in the range of about 0.04 to about 0.6.
12. the elastic foam described in claim 1, it further includes water, wherein the gross weight based on the elastic foam, institute The amount of water is stated in the range of 20 to about 60 wt.%.
13. the elastic foam described in claim 1, wherein the elastic foam is described derivative comprising 40 wt.% or more Polyanionic polysaccharide.
14. the elastic foam described in claim 1, wherein the elastic foam is by including the derivative polyanionic polysaccharide Hydrogel is obtained, wherein the hydrogel has 200 Pa or higher or the surrender in the range of about 200 Pa to about 4000 Pa Stress.
15. the elastic foam described in claim 18, wherein the hydrogel is about the 3 to 15 of the hydrogel comprising amount The wt.% derivative polyanionic polysaccharide.
16. the elastic foam described in claim 1, wherein the elastic foam is flexible.
17. the elastic foam described in claim 20, wherein the elastic foam can absorb 60 wt.% or less water and guarantor Hold elasticity.
18. the elastic foam described in claim 1, wherein the elastic foam is non-liquid, illiquidity foam.
19. the elastic foam described in claim 1, wherein the derivative polyanionic polysaccharide is not crosslinking, or comprising most A small amount of crosslinkings.
20. the elastic foam described in claim 1, wherein the derivative polyanionic polysaccharide and/or elastic foam are not subjected to Cross linking conditions.
21. the elastic foam described in claim 1, wherein being nondeliquescent when the elastic foam is exposed to vapor.
22. thixotroping hydrogel, it is included:
(a) polyanionic polysaccharide derived from, it has the non-uniform Distribution of deriveding group;With
(b) water,
Wherein described hydrogel has thixotropic nature.
23. the thixotroping hydrogel described in claim 22, wherein the derivative polyanionic polysaccharide is carboxymethyl cellulose, second Base cellulose sulfonate, carboxy methyl amylose, 6- chondroitin sulfates, chondroitin-4-suleate, dermatan sulfate, alginates, heparin, Or heparin sulfate or its any combinations.
24. the thixotroping hydrogel described in claim 24, wherein the derivative polyanionic polysaccharide is carboxymethyl cellulose.
25. the thixotroping hydrogel described in claim 24, wherein the thixotroping hydrogel has three-dimensional structure, and it is wherein described Water is included in the three-dimensional structure.
26. the thixotroping hydrogel described in claim 24, wherein the thixotroping hydrogel is dissolved in the water when being contacted with water.
27. preparing the method for the elastic foam described in claim 1, methods described includes:
(a) hydrogel for including derivative polyanionic polysaccharide is obtained;
(b) hydrogel is made to be subjected to the condition for being enough to freeze the water cooling being included in the hydrogel;
(c) hydrogel from step (b) is made to be subjected to being enough the drying steps to form open celled foam;With
(d) open celled foam from step (c) is made to contact to form the elastic foam with water.
28. the method described in claim 27, wherein the condition bag for being enough to freeze the water cooling being included in the hydrogel Include the min of temperature 1 to 30 min for making the hydrogel be subjected to 0 °C to -5 °C.
29. the method described in claim 27, wherein the drying steps (b) and the freezing step (c) include making step (a) In the hydrogel be subjected to freezing.
It is described to be formed that 30. the open celled foam in the method described in claim 29, wherein step (d) absorbs enough water Elastic foam, wherein the elastic foam can be deformed after pressure application and to return back to its after the pressure is removed original Shape.
CN201580051732.6A 2014-07-24 2015-06-09 Many sugarwhips of elasticity and application thereof CN107075165A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US201462028508P true 2014-07-24 2014-07-24
US62/028508 2014-07-24
PCT/US2015/034902 WO2016014158A1 (en) 2014-07-24 2015-06-09 Resilient polysaccharide foams and uses thereof

Publications (1)

Publication Number Publication Date
CN107075165A true CN107075165A (en) 2017-08-18

Family

ID=54545415

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580051732.6A CN107075165A (en) 2014-07-24 2015-06-09 Many sugarwhips of elasticity and application thereof

Country Status (5)

Country Link
US (2) US10227478B2 (en)
EP (1) EP3172265A1 (en)
CN (1) CN107075165A (en)
AU (2) AU2015294612B2 (en)
WO (1) WO2016014158A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376320B2 (en) * 2016-05-11 2019-08-13 Affera, Inc. Anatomical model generation

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0747420A1 (en) * 1995-06-07 1996-12-11 Albany International Research Company Method of producing polysaccharide foams
EP0815879A2 (en) * 1996-06-28 1998-01-07 JOHNSON & JOHNSON MEDICAL, INC. Bioabsorbable medical devices from oxidized polysaccharides
US5718916A (en) * 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products
US20030187381A1 (en) * 2001-12-28 2003-10-02 Genzyme Corporation Bioresorbable foam packing device and use thereof
US20040224021A1 (en) * 2003-04-25 2004-11-11 Hossein Omidian Formation of strong superporous hydrogels
CN102099060A (en) * 2008-04-24 2011-06-15 麦德托尼克公司 Cold ionizing radiation sterilization
EP2562212A1 (en) * 2010-04-22 2013-02-27 Teijin Limited Hydrogel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6015641B2 (en) 1981-03-18 1985-04-20 Kao Soap Co
ES2388688T3 (en) * 1998-07-01 2012-10-17 Convatec Limited Shelters and materials suitable for use in them
US8313762B2 (en) 2006-07-05 2012-11-20 Medtronic Xomed, Inc. Flexible bioresorbable hemostatic packing and stent
US20130274349A1 (en) * 2012-04-12 2013-10-17 Jian Qin Open-celled foam with superabsorbent material and process for making the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0747420A1 (en) * 1995-06-07 1996-12-11 Albany International Research Company Method of producing polysaccharide foams
EP0815879A2 (en) * 1996-06-28 1998-01-07 JOHNSON & JOHNSON MEDICAL, INC. Bioabsorbable medical devices from oxidized polysaccharides
US5718916A (en) * 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products
US20030187381A1 (en) * 2001-12-28 2003-10-02 Genzyme Corporation Bioresorbable foam packing device and use thereof
US20040224021A1 (en) * 2003-04-25 2004-11-11 Hossein Omidian Formation of strong superporous hydrogels
CN102099060A (en) * 2008-04-24 2011-06-15 麦德托尼克公司 Cold ionizing radiation sterilization
EP2562212A1 (en) * 2010-04-22 2013-02-27 Teijin Limited Hydrogel

Also Published As

Publication number Publication date
US20160024285A1 (en) 2016-01-28
AU2015294612B2 (en) 2019-07-11
AU2019246910A1 (en) 2019-10-31
AU2015294612A1 (en) 2017-02-09
WO2016014158A1 (en) 2016-01-28
EP3172265A1 (en) 2017-05-31
US10227478B2 (en) 2019-03-12
US20190136016A1 (en) 2019-05-09

Similar Documents

Publication Publication Date Title
US9675728B2 (en) Compositions for wound treatment
KR101148248B1 (en) Wound dressing and method for controlling severe, life-threatening bleeding
AU2005262070B2 (en) Haemostatic composition comprising hyaluronic acid
Khan et al. Polysaccharides and their derivatives for versatile tissue engineering application
ES2349775T3 (en) Hemostatic devices and compositions that include oxidized cellulose particles and a polisacarium binder.
EP2572702B1 (en) Biodegradable single-phase cohesive hydrogel
EP0906764B1 (en) Biopolymer sponge tubes
CN101534762B (en) Porous bioresorbable dressing conformable to a wound and methods of making same
ES2700161T3 (en) Methods to obtain lyophilized super-absorbent hydrogels for medical applications
CA2691413C (en) Reinforced composite implant
US20110262489A1 (en) Hyaluronic acid cryogel - compositions, uses, processes for manufacturing
EP1988942B1 (en) Gelled composite
EP1615589B1 (en) Planar implant
US20030148994A1 (en) Hemostatic composition
RU2442612C2 (en) Fast-acting sealing and the methods of its application and production
US5851229A (en) Bioresorbable sealants for porous vascular grafts
AU773826B2 (en) Hyaluronic acid gel composition, process for producing the same, and medical material containing the same
CN100548249C (en) Trauma dressing for hematischesis and its preparation method
AU2009233626B2 (en) Delayed gelation compositions and methods of use
KR100721752B1 (en) Water-swellable polymer gel and process for preparing the same
US9272073B2 (en) Surgical patch
CN101361986B (en) Modified starch absorbable or biocompatible hemostasia material and preparation method thereof
EP1416946B1 (en) Expandable foam-like biomaterials and methods
CN101455857B (en) Biocompatibility modified starch sponges
JP2004290649A (en) Hemostatic bandage for injury and production method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination